Genetix Launches new CytoGenetix Reagents and Kits

Genetix Group plc announces the launch of a new range of reagents, CytoGenetix, which will be sold alongside its CytoVision® workstations.

According to Company, CytoVision® is the most widely used imaging and analysis cytogenetics workstation in the world for the investigation of chromosome abnormalities. CytoGenetix reagents and kits, used for fluorescent in situ hybridization (“FISH”), will complement a number of important genetic testing applications carried out on CytoVision® worldwide.

CytoGenetix probes are highly specific, have an excellent signal-to-noise ratio, and improved staining homogeneity so as to provide bright and clear results. Manufactured to exceptional standards of quality, precision and tolerance, CytoGenetix reagents may also be highly effective for use in any other cytogenetic system.

In addition, the Company believes the probes have further potential to expand this product line; in particular, research is being undertaken on how the probes may be used for the diagnosis and prognosis of cancer.